首页> Journal of immunology (Baltimore, Md. : 1950)> High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.

High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.

导出 OA

翻译打印收藏纠错

第一作者： Amina,Dawoodji

第一单位： Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom;

作者： Amina,Dawoodji ^[1] ; Ji-Li,Chen ^[1] ; Dawn,Shepherd ^[1] ; Frida,Dalin ^[2] ; Andrea,Tarlton ^[1] ; Mohammad,Alimohammadi ^[2] ; Marissa,Penna-Martinez ^[3] ; Gesine,Meyer ^[3] ; Anna L,Mitchell ^[4] ; Earn H,Gan ^[4] ; Eirik,Bratland ^[5] ; Sophie,Bensing ^[6] ; Eystein S,Husebye ^[5] ; Simon H,Pearce ^[4] ; Klaus,Badenhoop ^[3] ; Olle,Kämpe ^[7] ; Vincenzo,Cerundolo ^[8]

作者单位： Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom; ^[1] Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden; ^[2] Division of Endocrinology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany; ^[3] Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom; ^[4] Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway; Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway; ^[5] Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 77 Stockholm, Sweden; and. ^[6] Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden; Science for Life Laboratory, Uppsala University 750 03, Uppsala, Sweden. ^[7] Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom; vincenzo.cerundolo@imm.ox.ac.uk. ^[8]